RKDA Arcadia Biosciences Inc

Arcadia Biosciences Announces Kevin Comcowich Will Chair Board of Directors

Arcadia Biosciences, Inc. (Nasdaq: RKDA), an agricultural technology company, announced today that Kevin Comcowich has been elected to chair the board of directors, replacing George Gosbee who passed away last week.

Comcowich joined the Arcadia board as an independent director in 2016 and previously served as chair of the audit committee. He most recently served as the chief executive officer and portfolio manager of HTX Energy Fund in Houston, Texas. He is the former president and chief investment officer (CIO) of Sound Energy Partners and served as CIO and research analyst for Southport Energy Plus Partners fund. Comcowich received his MBA from the University of Indiana and earned his bachelor’s degree from the College of the Holy Cross.

“While I’m saddened by the loss of a good friend and colleague, I look forward to working with my fellow board members and Arcadia’s executive team to capitalize on the many opportunities the company has going forward,” said Comcowich.

The board also appointed Gregory Waller to chair the audit committee and Amy Yoder to chair the compensation committee.

About Arcadia Biosciences, Inc.

Based in Davis, Calif., Arcadia Biosciences (Nasdaq: RKDA) develops agricultural products that create added value for farmers, enhance human health and improve the environmental sustainability of agriculture. Arcadia’s nutrition traits and products are aimed at creating healthier ingredients and whole foods with lower production costs. Arcadia’s agronomic performance traits, including Nitrogen Use Efficiency, Water Use Efficiency, Salinity Tolerance, Heat Tolerance and Herbicide Tolerance, are all aimed at making agricultural production more economically efficient and environmentally sound. For more information, visit www.arcadiabio.com.

EN
21/11/2017

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Arcadia Biosciences Inc

 PRESS RELEASE

Arcadia Biosciences Announces First-Quarter 2018 Financial Results and...

DAVIS, Calif.--(BUSINESS WIRE)-- Arcadia Biosciences, Inc. (Nasdaq: RKDA), an agricultural food ingredient company, today released its financial and business results for the first quarter of 2018. “With the launch of our GoodWheat™ brand and notable technical achievements in our Resistant Starch and Reduced Gluten wheat products, 2018 is shaping up to be a game-changing year at Arcadia,” said Raj Ketkar, president and CEO. “We made a strong start in our commercialization plans for our wheat quality portfolio in the fir...

 PRESS RELEASE

Arcadia Biosciences’ Traits Increase Rice Yields By Double Digits

DAVIS, Calif.--(BUSINESS WIRE)-- Arcadia Biosciences (Nasdaq: RKDA), an agricultural food ingredient company, today announced field trials results from the past two crop seasons showing significant yield gains in rice with three of Arcadia’s proprietary input traits stacked together. In the trials, conducted at the International Center for Tropical Agriculture (CIAT) in Colombia, multiple rice lines carrying the nitrogen use efficiency (NUE), water use efficiency (WUE) and salinity tolerance (ST) traits outperformed appropriate...

 PRESS RELEASE

Arcadia Biosciences Announces Date of First-Quarter 2018 Financial Res...

DAVIS, Calif.--(BUSINESS WIRE)-- Arcadia Biosciences, Inc. (Nasdaq: RKDA), an agricultural food ingredient company, today announced its plan to release its first-quarter 2018 financial and business results after market close on May 9, 2018. The company has scheduled a conference call for 4:30 p.m. Eastern time (1:30 p.m. Pacific time) to discuss first-quarter results and the quarter’s key strategic achievements. Interested participants can join the conference call using the following numbers: ...

 PRESS RELEASE

Arcadia Biosciences Expands GoodWheatâ„¢ Portfolio with Reduced Gluten...

DAVIS, Calif.--(BUSINESS WIRE)-- Arcadia Biosciences (Nasdaq: RKDA), an agricultural food ingredient company, today announced plans to add its new reduced gluten (RG) wheat lines to its GoodWheat™ portfolio of branded ingredients. The company expects to have its first RG bread wheat flour available for commercial testing by the end of the year. Arcadia’s reduced gluten wheat, developed through research funded in part by a grant from the U.S. National Institutes of Health’s Diabetes and Digestive and Kidney Disorders In...

 PRESS RELEASE

Arcadia Biosciences Announces Fourth-Quarter and Full-Year 2017 Financ...

DAVIS, Calif.--(BUSINESS WIRE)-- Arcadia Biosciences, Inc. (Nasdaq: RKDA), a consumer-driven, agricultural food ingredient company, today released its financial and business results for the fourth quarter and full year of 2017. “2017 was a pivotal year for Arcadia as we sharpened our focus on the commercialization of our non-GM quality and nutrition ingredient traits for the $200B global wheat flour market and demonstrated steady advancement towards the commercialization of our high-value agricultural productivity traits in A...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch